Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients

Clinical trial NCT05410275 · RECRUITING

Trial details

NCT number: NCT05410275
Sponsor: University Hospital, Tours
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hemodialysis Patients

Start date: 2025-01-08
Primary completion: 2027-01-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.